Each year I make a list of predictions for the stem cell and regenerative medicine field for the coming new year. Later in this post I list my top 20 stem cell predictions for 2017. In looking at my past predictions I realized this will now be my 7th year doing stem cell/regenerative medicine yearly predictions. […]
Stem Cell Predictions for 2017 Read More »
Some amniotic stem cell clinics seem to be trying to have their cake and eat it too. Generally the amniotic stem cell clinics market their products as “stem cells” and the implication is that living stem cells are used to effectively treat many medical conditions. I have not seen it mentioned that what some of
Wanted both dead & alive: amniotic stem cell clinics sell zombie cells? Read More »
What are the hottest stem cell trends in the field today? Depends who you ask, right? One impartial way to look at stem cell trends is through the lens of publication citations and the focuses of top stem cell papers. In that perhaps somewhat skewed, but interesting approach, the words used in the titles of the
Text mining hottest 50 papers reveals hottest 2016 stem cell trends Read More »
The voting on the 20 nominees for Stem Cell Person of the Year finished at midnight last night. After more than 1,000 votes, we have the top 10 finalists. These ten are some of the most remarkable people in the world of stem cells today. They have all had great impact, but in very diverse
10 finalists for Stem Cell Person of the Year 2016 Read More »
Recently I had the opportunity to talk with the leadership of Asterias, a California biotech doing exciting clinical research using stem cells as the basis for treatment of spinal cord injury. The interview covers the past (Geron patients), present, and future. I spoke with Asterias President and CEO Stephen Cartt and CMO Edward Wirth. How
Asterias interview: stem cell spinal cord injury trials advance Read More »
Some stem cell news headlines from the past week for you folks. Neuroscience: New nerves for old. Fixing stuff like strokes and paralysis. Cambridge’s Gurdon Institute and Stem Cell Institute receive five-year funding boost. Money flow to stem cells FDA “talks” stem cells in NEJM, “Clarifying Stem-Cell Therapy’s Benefits and Risks”, published on same day that 21st Century
Top stem cell & regenerative medicine headlines of the week Read More »
There is a growing trend of apparently unhappy patients suing stem cell clinics, which have faced more lawsuits recently and some of these cases are proposed class action suits that could have much broader impact. The latest case is against San Diego-based Stemgenex, a clinic that has claimed amongst other things that it can treat numerous diverse afflictions and that
Stem cell clinic lawsuits proliferate with latest against Stemgenex Read More »
I received a score of great nominations for the Stem Cell Person of the Year 2016 Award and have briefly described the twenty nominees below. The point of the award is to honor the top positive stem cell leader who specifically thinks outside the box and takes risks. I’ve started an on-line vote where you can vote once per day for
20 Nominees for Stem Cell Person of the Year 2016 Award Read More »
The 21st Century Cures Act has some important provisions that would impact the stem cell and regenerative medicine field. What is driving these efforts is a widespread sense that the status quo of regenerative medicine oversight isn’t working very well. I’m talking with key stakeholders and still trying to sort out my thoughts on the
Perspectives on Cures Act stem cell provisions possible benefits & risks Read More »
Concerns over stem cell clinics allegedly causing blindness or other vision problems have been increasing in 2016. If this is in fact happening, the extra sad part of this is that some clinics have claimed that they are doing the opposite: improving vision in patients. What are the concerns? Earlier this year a publicly-traded stem
2nd lawsuit alleging a U.S. stem cell clinic caused blindness Read More »